title: Retrospective comparison of Traditional vs. LigaSure impact dissection during pancreatoduodenectomy: how to save money by using an expensive device.
abstract: Pancreatoduodenectomy is an exceptional procedure that requires an extensive dissection of the supramesocolic region extended to the first jejunal limb. Lymphadenectomy, required for cancer, increases the dissection surface. The extensive preparation of the area is traditionally conducted with bipolar ormonopolar instruments, while clips, ligatures, and sutures are used for haemostasis. LigaSure™ vessel sealing(LSVS; Valleylab, Boulder, CO) is a technology that obtains vessel closure by using the body's own collagen and elastin to create a permanent fusion zone. This is obtained by a combination of forceps pressure and radio frequency. This effect has been improved by the introduction of the Force Triad™ (Valleylab, Boulder,CO) energy platform, controlled by TissueFect™ (Valleylab, Boulder, CO) sensing technology. With this device, the surgeon is able to fuse vessels up to 7 mm, lymphatics, tissue bundles, and pulmonary vasculature in a fast-seal cycle of almost 4 seconds. In our daily practice of open surgery we observe a rapid improvement of abdominal drainage output with a drastic reduction of protein loss. Its practical significance is, in our opinion, that we obtain a rapid recovery of normal serum protein levels with a low number of blood/plasmasac transfusions and a real improvement of anastomosis healing. Moreover, the efficacy and the speed of work of the device allow us to reduce the operating time significantly but safely. We performed a retrospective analysis of the data of 20 pancreatic resections conducted both with traditional dissection and with the Liga-Sure Impact device with Force Triad platform in order to verify whether observed data were real. Our clinical results show that the use of the LigaSure Impact device with Force Triad energy platform is really useful in open surgery to save operating time, number of postoperative days, and hemoderivate administration.
authors.affiliation: University of Bari Bari, Italy.
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Piccinni
authors.affiliation: University of Bari Bari, Italy.
authors.forename: Alessandro
authors.initials: A
authors.lastname: Pasculli
authors.affiliation: University of Bari Bari, Italy.
authors.forename: Erasmina
authors.initials: E
authors.lastname: D'Ambrosio
authors.affiliation: University of Bari Bari, Italy.
authors.forename: Angela
authors.initials: A
authors.lastname: Gurrado
authors.affiliation: European Institute of Oncology Milano, Italy.
authors.forename: Germana
authors.initials: G
authors.lastname: Lissidini
authors.affiliation: University of Bari Bari, Italy.
authors.forename: Mario
authors.initials: M
authors.lastname: Testini
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D017046:Cost Savings / Q000191:economics / Q000379:methods; D005260:Female; D017048:Health Care Costs; D006488:Hemostasis, Surgical / Q000191:economics* / Q000295:instrumentation*; D006801:Humans; D007558:Italy; D008026:Ligation / Q000191:economics / Q000295:instrumentation; D008297:Male; D008875:Middle Aged; D010190:Pancreatic Neoplasms / Q000191:economics* / Q000601:surgery*; D016577:Pancreaticoduodenectomy / Q000191:economics* / Q000295:instrumentation* / Q000379:methods; D012189:Retrospective Studies; D016896:Treatment Outcome